{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T01:18:58Z","timestamp":1789780738742,"version":"4.0.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Programa Pesquisa para o SUS","award":["003\/2017"],"award-info":[{"award-number":["003\/2017"]}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002973","name":"Daiichi Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cristalia Produtos Qu\u00edmicos e Farmac\u00eauticos"},{"name":"Libbs"},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Myralis Farma"},{"name":"Ach\u00e9 Laborat\u00f3rios"},{"name":"Hypera Pharma"},{"DOI":"10.13039\/100008976","name":"Sanofi-Aventis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008976","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"Servier Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Forum Pharmaceuticals"},{"name":"Daiichi Sankyo Brasil"},{"name":"Lundbeck Brasil"},{"name":"Moksha8 Brasil"},{"name":"Takeda Brasil"},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi Aventis","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Torrent Pharma"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.jad.2019.11.086","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T00:12:38Z","timestamp":1573690358000},"page":"527-534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":181,"special_numbering":"C","title":["Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study"],"prefix":"10.1016","volume":"264","author":[{"given":"Fernanda S.","family":"Correia-Melo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo C.","family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1via","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula","family":"Jesus-Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo P.","family":"Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme","family":"Magnavita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Teresa","family":"Caliman-Fontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana V.F.","family":"Echegaray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor D.","family":"Bandeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha S.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diogo E.","family":"Cavalcanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Ara\u00fajo-de-Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana M.","family":"Sarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco A.","family":"Tuena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Nakahira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline S.","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"Del-Porto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Turecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Loo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Acioly L.T.","family":"Lacerda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas C.","family":"Quarantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jad.2019.11.086_bib59","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1590\/S1516-44462000000300003","article-title":"Mini International Neuropsychiatric Interview (MINI): valida\u00e7\u00e3o de entrevista breve para diagn\u00f3stico de transtornos mentais","volume":"22","author":"Amorim","year":"2000","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.jad.2019.11.086_bib0001","doi-asserted-by":"crossref","first-page":"e674","DOI":"10.4088\/JCP.17f11681","article-title":"Ketamine for depression, 3: does chirality matter?","volume":"78","author":"Andrade","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2019.11.086_bib0002","doi-asserted-by":"crossref","first-page":"170","DOI":"10.5116\/ijme.5b1b.b0a2","article-title":"Medical education and leadership: a call to action for Brazil's mental health system","volume":"9","author":"Bandeira","year":"2018","journal-title":"Int. J. Med. Educ."},{"key":"10.1016\/j.jad.2019.11.086_bib0003","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2019.11.086_bib0004","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/A:1024465317902","article-title":"Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS)","volume":"11","author":"Bremner","year":"1998","journal-title":"J. Trauma. Stress"},{"key":"10.1016\/j.jad.2019.11.086_bib0005","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011612.pub2","article-title":"Ketamine and other glutamate receptor modulators for depression in adults","author":"Caddy","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jad.2019.11.086_bib0006","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1176\/appi.ajp.2018.17060720","article-title":"Efficacy and safety of intranasal esketamine for the rapid reduction of symptoms of depression and suicidality in patients at imminent risk for suicide: results of a double-blind, randomized, placebo-controlled study","volume":"175","author":"Canuso","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2019.11.086_bib0007","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pbb.2019.04.008","article-title":"Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine","volume":"181","author":"Chang","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jad.2019.11.086_bib0008","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.2147\/NDT.S135623","article-title":"Rapid infusion of esketamine for unipolar and bipolar depression: a retrospective chart review","volume":"13","author":"Correia-Melo","year":"2017","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2019.11.086_bib0009","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012414","article-title":"Comparative study of esketamine and racemic ketamine in treatment-resistant depression","volume":"97","author":"Correia-Melo","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jad.2019.11.086_bib0010","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1590\/1516-4446-2016-2070","article-title":"S-(+)-ketamine-induced dissociative symptoms as a traumatic experience in patients with treatmentresistant depression","volume":"39","author":"Correia-Melo","year":"2017","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.jad.2019.11.086_bib0011","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/hup.2475","article-title":"The use of ketamine as an antidepressant: a systematic review and meta-analysis","volume":"30","author":"Coyle","year":"2015","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"10.1016\/j.jad.2019.11.086_bib0012","unstructured":"Daly, E.J., Trivedi, M.H., Janik, A., Li, H., Zhang, Y., Li, X., Lane, R., Lim, P., Duca, A.R., Hough, D., Thase, M.E., Zajecka, J., Winokur, A., Divacka, I., Fagiolini, A., Cubala, W.J., Bitter, I., Blier, P., Shelton, R.C., Molero, P., Manji, H., Drevets, W.C., Singh, J.B., n.d.Esketamine nasal spray plus oral antidepressant treatment in patients with treatment-resistant depression. JAMA Psychiatry.10.1001\/jamapsychiatry.2019.1189."},{"key":"10.1016\/j.jad.2019.11.086_bib0013","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-2999(97)01116-3","article-title":"Norketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord","volume":"333","author":"Ebert","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jad.2019.11.086_bib0014","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0006-3223(03)00231-2","article-title":"Diagnosis and definition of treatment-resistant depression","volume":"53","author":"Fava","year":"2003","journal-title":"Biol. Psychiatry"},{"issue":"Suppl 6","key":"10.1016\/j.jad.2019.11.086_bib0015","first-page":"10","article-title":"Treatment of major depression: is improvement enough?","volume":"60","author":"Ferrier","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jad.2019.11.086_bib0016","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1007\/s00213-014-3664-5","article-title":"Ketamine administration in depressive disorders: a systematic review and meta-analysis","volume":"231","author":"Fond","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jad.2019.11.086_bib0017","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1124\/jpet.116.239228","article-title":"Antidepressant potential of (R)-ketamine in rodent models: comparison with (S)-ketamine","volume":"361","author":"Fukumoto","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jad.2019.11.086_bib0018","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/bja\/70.6.666","article-title":"Pharmacokinetics and pharmacodynamics of ketamine enantiomers in surgical patients using a stereoselective analytical method","volume":"70","author":"Geisslinger","year":"1993","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.jad.2019.11.086_bib0019","article-title":"ECDEU assessment manual for psychopharmacology: revised","author":"Guy","year":"1976"},{"key":"10.1016\/j.jad.2019.11.086_bib0020","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.2147\/NDT.S117146","article-title":"Efficacy of ketamine in the rapid treatment of major depressive disorder: a meta-analysis of randomized, double-blind, placebo-controlled studies","volume":"12","author":"Han","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2019.11.086_bib0021","doi-asserted-by":"crossref","DOI":"10.1111\/pcn.12902","article-title":"Rapid\u2010acting antidepressant ketamine, its metabolites and other candidates: a historical overview and future perspective","author":"Hashimoto","year":"2019","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2019.11.086_bib0022","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.biopsych.2018.07.018","article-title":"Mechanisms of the antidepressant effects of ketamine enantiomers and their metabolites","volume":"84","author":"Ide","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2019.11.086_bib0023","first-page":"53","article-title":"Remission versus response: the new gold standard of antidepressant care","volume":"65","author":"Keller","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2019.11.086_bib0024","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.genhosppsych.2015.01.003","article-title":"Ketamine as a novel treatment for major depressive disorder and bipolar depression: a systematic review and quantitative meta-analysis","volume":"37","author":"Lee","year":"2015","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.jad.2019.11.086_bib0025","first-page":"3","article-title":"The increasing burden of depression","volume":"7","author":"L\u00e9pine","year":"2011","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2019.11.086_bib0026","first-page":"1","article-title":"Off-label use of ketamine for treatment-resistant depression in clinical practice: european perspective","author":"L\u00f3pez-D\u00edaz","year":"2019","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2019.11.086_bib0027","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1017\/S0033291714001603","article-title":"A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes","volume":"45","author":"McGirr","year":"2015","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2019.11.086_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2013.10.043","article-title":"Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach","volume":"156","author":"McIntyre","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2019.11.086_bib0029","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2019.11.086_bib0030","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2019.11.086_bib0031","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jad.2018.11.038","article-title":"Definition of treatment-resistant depression \u2013 Asia Pacific perspectives","volume":"245","author":"Ng","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2019.11.086_bib0032","first-page":"7","article-title":"Evolution of remission as the new standard in the treatment of depression","volume":"60","author":"Nierenberg","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2019.11.086_bib0033","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/15622970701714370","article-title":"Comparison of racemic ketamine and s -ketamine in treatment-resistant major depression: report of two cases","volume":"10","author":"Paul","year":"2009","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2019.11.086_bib0034","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1001\/jama.2012.87802","article-title":"Reporting of noninferiority and equivalence randomized trials","volume":"308","author":"Piaggio","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jad.2019.11.086_bib0035","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a star*d report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2019.11.086_bib0036","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/jamapsychiatry.2017.0080","article-title":"A consensus statement on the use of ketamine in the treatment of mood disorders","volume":"74","author":"Sanacora","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2019.11.086_bib0037","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/jcph.122","article-title":"Repeated S-ketamine infusions in therapy resistant depression: a case series","volume":"53","author":"Segmiller","year":"2013","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jad.2019.11.086_bib0038","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2215-0366(17)30272-9","article-title":"Side-effects associated with ketamine use in depression: a systematic review","volume":"5","author":"Short","year":"2018","journal-title":"The Lancet Psychiatry"},{"key":"10.1016\/j.jad.2019.11.086_bib0039","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.biopsych.2015.10.018","article-title":"Intravenous esketamine in adult treatment-resistant depression: a double-blind, double-randomization, placebo-controlled study","volume":"80","author":"Singh","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2019.11.086_bib0040","first-page":"57","article-title":"Relationship of ketamine's antidepressant and psychotomimetic effects in unipolar depression","volume":"55","author":"Sos","year":"2013","journal-title":"Act. Nerv. Super. Rediviva"},{"key":"10.1016\/j.jad.2019.11.086_bib0041","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0924-977X(98)00004-2","article-title":"Treatment resistant depression: methodological overview and operational criteria","volume":"9","author":"Souery","year":"1999","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2019.11.086_bib0042","first-page":"18","article-title":"Evaluating antidepressant therapies: remission as the optimal outcome","volume":"64","author":"Thase","year":"2003","journal-title":"J. Clin. Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.jad.2019.11.086_bib0043","first-page":"23","article-title":"When at first you don't succeed: sequential strategies for antidepressant nonresponders","volume":"58","author":"Thase","year":"1997","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2019.11.086_bib0044","article-title":"Esketamine nasal spray approved for treatment-resistant depression","volume":"76","author":"Traynor","year":"2019","journal-title":"Am. J. Heal. Pharm."},{"key":"10.1016\/j.jad.2019.11.086_bib0045","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/104012371402600310","article-title":"Defining treatment-resistant depression: a comprehensive review of the literature","volume":"26","author":"Trevino","year":"2014","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2019.11.086_bib0046","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.8017br6c.e01","article-title":"Treating depression to full remission","volume":"70","author":"Trivedi","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2019.11.086_bib0047","unstructured":"Urbaniak, G. C., & Plous, S., 2013. Research Randomizer (Version 4.0). Retrieved from http:\/\/www.randomizer.org\/. (accessed 02 February 2017)."},{"key":"10.1016\/j.jad.2019.11.086_bib0048","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0924-977X(96)00042-9","article-title":"Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)","volume":"7","author":"Vollenweider","year":"1997","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2019.11.086_bib0049","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4088\/JCP.13m08852","article-title":"Ketamine safety and tolerability in clinical trials for treatment-resistant depression","volume":"76","author":"Wan","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2019.11.086_bib0050","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00000542-198003000-00008","article-title":"Pharmacology of ketamine isomers in surgical patients","volume":"52","author":"White","year":"1980","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.jad.2019.11.086_bib0051","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/bja\/57.2.197","article-title":"Comparative pharmacology of the ketamine isomers. Studies in volunteers","volume":"57","author":"White","year":"1985","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jad.2019.11.086_bib0052","series-title":"Depression and Other Common Mental disorders: Global Health Estimates","year":"2017"},{"key":"10.1016\/j.jad.2019.11.086_bib0053","doi-asserted-by":"crossref","first-page":"pyv124","DOI":"10.1093\/ijnp\/pyv124","article-title":"Effects of low-dose and very low-dose ketamine among patients with major depression: a systematic review and meta-analysis","volume":"19","author":"Xu","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2019.11.086_bib0054","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.136","article-title":"R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects","volume":"5","author":"Yang","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2019.11.086_bib0055","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.117.015198","article-title":"Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms","volume":"70","author":"Zanos","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jad.2019.11.086_bib0056","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2019.11.086_bib0057","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.pbb.2013.11.033","article-title":"R (\u2212)-ketamine shows greater potency and longer lasting antidepressant effects than s (+)-ketamine","volume":"116","author":"Zhang","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jad.2019.11.086_bib0058","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1176\/appi.ajp.163.1.148","article-title":"How should remission from depression be defined? The depressed patient's perspective","volume":"163","author":"Zimmerman","year":"2006","journal-title":"Am. J. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032719319780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032719319780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:38:12Z","timestamp":1759023492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032719319780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":59,"alternative-id":["S0165032719319780"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2019.11.086","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2019.11.086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}